Michael Reindl

Michael Reindl is a seasoned professional with extensive experience in clinical development and operations within the biopharmaceutical industry. Currently serving as Group Lead for Clinical Development/Clinical Operations at LimmaTech Biologics AG, Michael has previously held senior leadership roles, including Senior Director and Head EU Clinical Operations at Arena Pharmaceuticals, Regional Head of Global Clinical Operations at Merck Group, and Director of Clinical Operations at CureVac AG. With a background that encompasses managing large-scale clinical trials across various phases and therapeutic areas, including gastroenterology, oncology, and infectious diseases, Michael demonstrates strong expertise in clinical trial management, cross-functional coordination, and team leadership. Michael holds a Ph.D. in Toxicology from Johannes Gutenberg University Mainz and a Diploma in Chemistry from The Julius Maximilians University of Würzburg.